ABCAM PLC/ADR (ABCZY) Upgraded by Zacks Investment Research to “Hold”
Zacks Investment Research upgraded shares of ABCAM PLC/ADR (OTCMKTS:ABCZY) from a sell rating to a hold rating in a report released on Monday.
According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “
Shares of ABCAM PLC/ADR stock opened at $15.74 on Monday. ABCAM PLC/ADR has a one year low of $12.75 and a one year high of $20.29.
About ABCAM PLC/ADR
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents.
See Also: Bear Market – How and Why They Occur
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ABCAM PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABCAM PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.